PL1820022T3 - Zastosowanie analizy metodą cytometrii przepływowej w optymalizacji strategii dla banków komórek jajnika chińskiego chomika - Google Patents

Zastosowanie analizy metodą cytometrii przepływowej w optymalizacji strategii dla banków komórek jajnika chińskiego chomika

Info

Publication number
PL1820022T3
PL1820022T3 PL05803011T PL05803011T PL1820022T3 PL 1820022 T3 PL1820022 T3 PL 1820022T3 PL 05803011 T PL05803011 T PL 05803011T PL 05803011 T PL05803011 T PL 05803011T PL 1820022 T3 PL1820022 T3 PL 1820022T3
Authority
PL
Poland
Prior art keywords
production
cell banks
flow cytometric
strategies
optimization
Prior art date
Application number
PL05803011T
Other languages
English (en)
Inventor
Hitto Kaufmann
Juergen Fieder
Ralf Otto
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PL1820022T3 publication Critical patent/PL1820022T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4718Lipocortins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL05803011T 2004-11-10 2005-11-07 Zastosowanie analizy metodą cytometrii przepływowej w optymalizacji strategii dla banków komórek jajnika chińskiego chomika PL1820022T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04026673 2004-11-10
PCT/EP2005/055784 WO2006051065A2 (en) 2004-11-10 2005-11-07 Use of flow-cytometric analysis to optimize cell banking strategies for cho cells
EP05803011A EP1820022B1 (en) 2004-11-10 2005-11-07 Use of flow-cytometric analysis to optimize cell banking strategies for cho cells

Publications (1)

Publication Number Publication Date
PL1820022T3 true PL1820022T3 (pl) 2009-11-30

Family

ID=36118077

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05803011T PL1820022T3 (pl) 2004-11-10 2005-11-07 Zastosowanie analizy metodą cytometrii przepływowej w optymalizacji strategii dla banków komórek jajnika chińskiego chomika

Country Status (15)

Country Link
US (2) US7569339B2 (pl)
EP (1) EP1820022B1 (pl)
JP (1) JP4620739B2 (pl)
KR (1) KR101235658B1 (pl)
AT (1) ATE433110T1 (pl)
CA (1) CA2578400C (pl)
CY (1) CY1110345T1 (pl)
DE (1) DE602005014805D1 (pl)
DK (1) DK1820022T3 (pl)
ES (1) ES2325931T3 (pl)
PL (1) PL1820022T3 (pl)
PT (1) PT1820022E (pl)
SI (1) SI1820022T1 (pl)
TW (1) TWI364459B (pl)
WO (1) WO2006051065A2 (pl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1820022T3 (pl) 2004-11-10 2009-11-30 Boehringer Ingelheim Pharma Zastosowanie analizy metodą cytometrii przepływowej w optymalizacji strategii dla banków komórek jajnika chińskiego chomika
AU2009314111A1 (en) * 2008-11-12 2010-05-20 Merck Sharp & Dohme Corp. BetaGI-IgG intron for enhanced anti-IGF1 R expression
HRP20230065T1 (hr) 2011-10-28 2023-03-03 Prothena Biosciences Limited Humanizirana protutijela koja prepoznaju alfa-sinuklein
SG11201404321YA (en) 2012-01-27 2014-08-28 Neotope Biosciences Ltd Humanized antibodies that recognize alpha-synuclein
UA118441C2 (uk) 2012-10-08 2019-01-25 Протена Біосаєнсиз Лімітед Антитіло, що розпізнає альфа-синуклеїн
MX375354B (es) 2013-03-13 2025-03-06 Prothena Biosciences Ltd Anticuerpos que se unen a tau y usos de los mismos.
US10513555B2 (en) 2013-07-04 2019-12-24 Prothena Biosciences Limited Antibody formulations and methods
WO2015004632A1 (en) 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize iapp
US9951131B2 (en) 2013-07-12 2018-04-24 Prothena Biosciences Limited Antibodies that recognize IAPP
JP2017501848A (ja) 2013-11-19 2017-01-19 プロセナ バイオサイエンシーズ リミテッド 便秘症状からのレビー小体病の免疫療法のモニター
TW201623331A (zh) 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
JP2017514458A (ja) 2014-03-12 2017-06-08 プロセナ バイオサイエンシーズ リミテッド Lg4−5に対して特異的な抗−ラミニン4抗体
CA2938931A1 (en) 2014-03-12 2015-09-17 Prothena Biosciences Limited Anti-laminin4 antibodies specific for lg1-3
KR20160127825A (ko) 2014-03-12 2016-11-04 프로테나 바이오사이언시즈 리미티드 항-mcam 항체 및 관련된 사용 방법
US10562973B2 (en) 2014-04-08 2020-02-18 Prothena Bioscience Limited Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
WO2016007752A1 (en) * 2014-07-09 2016-01-14 Genentech, Inc. Ph adjustment to improve thaw recovery of cell banks
TWI711631B (zh) 2015-01-28 2020-12-01 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI781507B (zh) 2015-01-28 2022-10-21 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
TWI718122B (zh) 2015-01-28 2021-02-11 愛爾蘭商普羅佘納生物科技有限公司 抗甲狀腺素運送蛋白抗體
CN104833625B (zh) * 2015-06-04 2018-02-23 武汉友芝友生物制药有限公司 表达重组抗体cho细胞系稳定性的早期鉴定方法
WO2017046774A2 (en) 2015-09-16 2017-03-23 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
EP3350226A2 (en) 2015-09-16 2018-07-25 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
WO2017149513A1 (en) 2016-03-03 2017-09-08 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
WO2017153953A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
WO2017153955A1 (en) 2016-03-09 2017-09-14 Prothena Biosciences Limited Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
CA3022673A1 (en) 2016-05-02 2017-11-09 Prothena Biosciences Limited Tau immunotherapy
CA3022515A1 (en) 2016-05-02 2017-11-09 Prothena Biosciences Limited Antibodies recognizing tau
EA201892412A1 (ru) 2016-05-02 2019-05-31 Протена Биосайенсис Лимитед Антитела, распознающие тау
WO2017208210A1 (en) 2016-06-03 2017-12-07 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
JP7017013B2 (ja) 2016-07-02 2022-02-08 プロセナ バイオサイエンシーズ リミテッド 抗トランスサイレチン抗体
EP3478714A2 (en) 2016-07-02 2019-05-08 Prothena Biosciences Limited Anti-transthyretin antibodies
JP7016470B2 (ja) 2016-07-02 2022-02-07 プロセナ バイオサイエンシーズ リミテッド 抗トランスサイレチン抗体
KR102784294B1 (ko) 2017-05-02 2025-03-19 프로테나 바이오사이언시즈 리미티드 타우 인식 항체
JP2021502955A (ja) 2017-09-28 2021-02-04 プロセナ・バイオサイエンシズ・リミテッド シヌクレイン病の治療のための投与レジメン
PE20210042A1 (es) 2017-10-06 2021-01-08 Prothena Biosciences Ltd Metodos para detectar transtiretina
AU2018375356A1 (en) 2017-11-29 2020-05-14 Neotope Neuroscience Limited Lyophilized formulation of a monoclonal antibody against transthyretin
EP3877410A4 (en) 2018-11-08 2022-08-10 Prothena Biosciences Limited ANTIBODIES RECOGNIZING TAU PROTEIN
AU2019386976B2 (en) 2018-11-26 2024-05-30 Forty Seven, LLC Humanized antibodies against c-Kit
EP3924464A4 (en) * 2019-02-11 2022-11-23 University of Virginia Patent Foundation SELECTION AND BLOCKING OF MALE AND FEMALE GAMETES SUITABLE FOR FERTILIZATION
CN119371527A (zh) 2019-03-03 2025-01-28 普罗塞纳生物科学有限公司 识别tau的抗体
AU2021297540A1 (en) 2020-06-24 2023-02-02 Prothena Biosciences Limited Antibodies recognizing sortilin
WO2025059491A2 (en) 2023-09-15 2025-03-20 Prothena Platform Technologies Limited Methods, compositions, and kits including cell-penetrating agents
AR133829A1 (es) 2023-09-15 2025-11-05 Othair Prothena Ltd Agentes penetrantes de células y usos de los mismos
AU2024341846A1 (en) 2023-09-15 2026-04-23 Prothena Biosciences Limited Cell penetrating agents and uses thereof
TW202530253A (zh) 2023-09-15 2025-08-01 愛爾蘭商普羅希那生物科學有限公司 抗tdp-43抗體及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1820022T3 (pl) 2004-11-10 2009-11-30 Boehringer Ingelheim Pharma Zastosowanie analizy metodą cytometrii przepływowej w optymalizacji strategii dla banków komórek jajnika chińskiego chomika

Also Published As

Publication number Publication date
US20100086947A1 (en) 2010-04-08
WO2006051065A2 (en) 2006-05-18
US20060121444A1 (en) 2006-06-08
ATE433110T1 (de) 2009-06-15
PT1820022E (pt) 2009-08-05
JP4620739B2 (ja) 2011-01-26
EP1820022B1 (en) 2009-06-03
ES2325931T3 (es) 2009-09-24
CA2578400A1 (en) 2006-05-18
WO2006051065A3 (en) 2006-08-03
CY1110345T1 (el) 2015-04-29
US7569339B2 (en) 2009-08-04
TWI364459B (en) 2012-05-21
KR20070090187A (ko) 2007-09-05
JP2008518611A (ja) 2008-06-05
TW200634161A (en) 2006-10-01
CA2578400C (en) 2014-01-14
SI1820022T1 (sl) 2009-10-31
DK1820022T3 (da) 2009-09-14
EP1820022A2 (en) 2007-08-22
KR101235658B1 (ko) 2013-02-21
DE602005014805D1 (de) 2009-07-16

Similar Documents

Publication Publication Date Title
TW200634161A (en) Use of flow-cytrometric analysis to optimize cell banking strategies for cho cells
Yuan et al. Exponential stability and periodic solutions of fuzzy cellular neural networks with time-varying delays
Lambeck et al. Sea level and shoreline reconstructions for the Red Sea: isostatic and tectonic considerations and implications for hominin migration out of Africa
Lonergan et al. The ART of studying early embryo development: progress and challenges in ruminant embryo culture
DK2218776T3 (da) Dyreproteinfrit celledyrkningsmedie til dyrkning af celler
HRP20150251T1 (en) Kit for predicting implantation success in assisted fertilisation
CL2008001159A1 (es) Metodo para producir una proteina en un cultivo de celulas que comprende cultivar celulas a una temperatura reducida y/o cultivar celulas a un ph reducido para minimizar la produccion de proteinas mal plegadas y/o proteinas agregadas.
WO2006088867A3 (en) Method for expansion of stem cells
WO2009016078A3 (en) Method for culturing mammalian stem cells
NO20071486L (no) Dyrking av humane embryonale stamceller
SE0401424L (sv) Analysanordning med reglerat flöde och motsvarande förfarande
EA201691174A1 (ru) Способ скрининга клеток
NO20083274L (no) Fremgangsmate for a vurdere levedyktigheten til tinte celler
CN102719427A (zh) 碱性裂解提取dna的方法
ATE336567T1 (de) Zellkulturmedium
US20030022203A1 (en) Cellular Arrays
ATE499598T1 (de) Markierungsfreier einzelzelltest
ATE507326T1 (de) Systeme und verfahren zur betriebssteuerung von metallelektrolysezellen
RU2011103549A (ru) Предшественник искусственной почки и способ его получения
EP1964918B8 (en) Protein which can serve as nucleus for polymerization of protein polymer and process for production of cells comprising said nucleus
DK1851325T3 (da) Fremgangsmåde til påvisning af levedygtige celler i en prøve ved anvendelse af en virus
DK1598670T3 (da) Metode til immunobestemmelse af tartratresistent sur phosphatase 5b og kit til anvendelse derved
Yang et al. Research on system dynamics model of conveyance capacity in symmetric compound channels.
CN105734651B (zh) 一种多功能霍尔槽系统
ATE556321T1 (de) Analyse des gpcr-signalweges mit biosensor- zelltests